EPISODE · Jul 28, 2022 · 2 MIN
At-home ketamine therapy 'incredibly effective,' study finds; FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
from Becker's Healthcare Behavioral Health · host Becker's Healthcare
Randi Haseman gives updates on the Behavioral Health industry.
Embed this episode
NOW PLAYING
At-home ketamine therapy 'incredibly effective,' study finds; FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
0:00
2:46
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Becker's Healthcare Behavioral Health?
This episode is 2 minutes long.
When was this Becker's Healthcare Behavioral Health episode published?
This episode was published on July 28, 2022.
Can I download this Becker's Healthcare Behavioral Health episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!